Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Barrett

Showing results (811-820 of 845) with videos related to

Pageof 85
Sort By:
Nature Medicine|November 7, 2024
Collaboration between clinicians and vision-language models in radiology report generationRyutaro Tanno, David G T Barrett, Andrew Sellergren, et al.
Journal of Medicinal Chemistry|April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSVRichard L Mackman, Hon C Hui, Michel Perron, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Iscience|July 4, 2025
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancerAngela Florio, James Smadbeck, Sarah H Johnson, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus: advancing a priority research agenda for preparedness and responseEve M Lackritz, Lee-Ching Ng, Ernesto T A Marques, et al.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Epigenomics|May 22, 2023
Epigenomics may begin to explain <i>in vitro</i> differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancerLouis Y El Khoury, Wan Hsin Lin, James B Smadbeck, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Nature Genetics|March 25, 2014
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4Pilar Ramos, Anthony N Karnezis, David W Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade GliomasMohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, et al.
Pageof 85

Showing results (811-820 of 845) with videos related to

Sort By:
Pageof 85
Nature Medicine|November 7, 2024
Collaboration between clinicians and vision-language models in radiology report generationRyutaro Tanno, David G T Barrett, Andrew Sellergren, et al.
Journal of Medicinal Chemistry|April 9, 2021
Prodrugs of a 1'-CN-4-Aza-7,9-dideazaadenosine <i>C</i>-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSVRichard L Mackman, Hon C Hui, Michel Perron, et al.
Nature Communications|July 9, 2015
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Jillian Phallen, Vilmos Adleff, et al.
Iscience|July 4, 2025
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancerAngela Florio, James Smadbeck, Sarah H Johnson, et al.
The Lancet. Infectious Diseases|March 2, 2025
Zika virus: advancing a priority research agenda for preparedness and responseEve M Lackritz, Lee-Ching Ng, Ernesto T A Marques, et al.
Science Translational Medicine|March 22, 2022
Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in miceAlexandra Schäfer, David R Martinez, John J Won, et al.
Epigenomics|May 22, 2023
Epigenomics may begin to explain <i>in vitro</i> differential response to hypomethylating agents in MMR-D hypermethylated endometrial cancerLouis Y El Khoury, Wan Hsin Lin, James B Smadbeck, et al.
Hepatology (Baltimore, Md.)|September 2, 2022
Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancersBolni Marius Nagalo, Yumei Zhou, Emilien J Loeuillard, et al.
Nature Genetics|March 25, 2014
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4Pilar Ramos, Anthony N Karnezis, David W Craig, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 28, 2025
Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade GliomasMohamed F Ali, Cecile Riviere-Cazaux, Sarah H Johnson, et al.
Pageof 85